Successful Utilization of the GLP-1 Receptor Agonist Semaglutide in Treating the Manifestations of Recalcitrant Celiac Disease. Archives of Clinical and Biomedical Research, v. 9, n. 5, p. 392–395, 29 Sep.2025.